A detailed history of Ostrum Asset Management transactions in Incyte Corp stock. As of the latest transaction made, Ostrum Asset Management holds 12,386 shares of INCY stock, worth $852,280. This represents 0.04% of its overall portfolio holdings.

Number of Shares
12,386
Previous 21,605 42.67%
Holding current value
$852,280
Previous $1.49 Billion 49.74%
% of portfolio
0.04%
Previous 0.13%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

SELL
$60.0 - $75.26 $553,140 - $693,821
-9,219 Reduced 42.67%
12,386 $750 Million
Q4 2024

Feb 13, 2025

SELL
$65.08 - $83.38 $3.63 Million - $4.65 Million
-55,773 Reduced 72.08%
21,605 $1.49 Billion
Q3 2024

Nov 13, 2024

SELL
$57.33 - $68.61 $1.22 Million - $1.46 Million
-21,273 Reduced 21.56%
77,378 $5.11 Billion
Q2 2024

Aug 13, 2024

BUY
$51.18 - $63.75 $180,255 - $224,527
3,522 Added 3.7%
98,651 $5.98 Billion
Q4 2023

Feb 13, 2024

BUY
$52.16 - $64.19 $399,493 - $491,631
7,659 Added 8.76%
95,129 $5.97 Billion
Q3 2023

Nov 14, 2023

SELL
$57.77 - $65.93 $67,186 - $76,676
-1,163 Reduced 1.31%
87,470 $5.05 Billion
Q2 2023

Aug 11, 2023

SELL
$60.95 - $75.51 $37,362 - $46,287
-613 Reduced 0.69%
88,633 $5.52 Billion
Q1 2023

May 12, 2023

BUY
$70.23 - $86.01 $6.27 Million - $7.68 Million
89,246 New
89,246 $6.45 Billion

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Ostrum Asset Management Portfolio

Follow Ostrum Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ostrum Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Ostrum Asset Management with notifications on news.